'Community-Owned' Genomic and Health Data Platform Raises $4.6M

May 13, 2019
LunaDNA platform plans to take novel approach by rewarding individuals for sharing health data

LunaPBC, a San Diego-area company that says it is building a community-owned genomic and health data platform, has received $4.6 million in new funding, bringing the company's total funding to date to $7.6 million.

Investors in this round include ARCH Venture Partners, Bain Capital Ventures, F-Prime Capital, Illumina Ventures, and Osage University Partners. The startup’s LunaDNA platform is seeking to take a new approach by rewarding individuals for sharing health data. The company envisions providing value to pharmaceutical, insurance and healthcare IT companies, as they improve health outcomes through the discovery of new therapies and a deeper understanding of patient outcomes.

LunaDNA was created by the Public Benefit Corporation LunaPBC,  which was founded in 2017 and headquartered in La Jolla, Calif.

In December 2018, LunaDNA received what it called “precedent-setting” qualification from the U.S. Securities and Exchange Commission (SEC) to recognize an individual's genomic and health data as currency with which to acquire shares of ownership in the company.

“This unique offering ensures members share in the value created from research performed on the platform. Members have the opportunity to advance research, receive shares in the Company commensurate with their contribution activity, and engage with utility apps and partners that align with their interests,” the company said. LunaPBC said its business model is based on individual data control, transparency, and community, including protecting the anonymity of members. 

"The timing is right to be changing the paradigm in data stewardship. There is a growing dissatisfaction with the use and exploitation of personal health data today,” said Bob Kain, CEO and co-founder of LunaPBC, in a statement. “Our community ownership solution and its underlying technology provide individuals with transparency, control, and data dividends.”

The company said the new funding would be used to accelerate research partnerships, onboard new partners such as Genetic Alliance, and expand platform development and marketing teams.

Genetic Alliance, a nonprofit dedicated to providing people with tools to transform research, is leveraging LunaDNA's data stewardship model for its 45 disease communities representing more than 50,000 patients. LunaPBC's new funding is accelerating the integration of Genetic Alliance's Platform for Engaging Everyone Responsibly with LunaDNA, to provide individuals and communities with more resources to support their health management while maximizing research opportunities.

LunaDNA accepts DNA files from vendors including 23andMe, AncestryDNA, MyHeritage and FamilyTree DNA, as well as LunaDNA-generated health surveys. The acceptance of new information types will be accelerated as a result of the new funding and include whole genome and exome DNA files, RNA, microbiome, electronic health records (EHRs), fitness and activity trackers, and smart devices, the company added.

Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?